Table 1.
Subunit | Functional effects | Tissue Distribution |
---|---|---|
α2δ1 | Trafficking α1 to membrane Increases current amplitude Activating/Inactivating calcium gating-kinetetics Site of extracellular ligand interaction Voltage dependence |
Brain, heart, skeletal muscle, bone |
α2δ2 | Increases current amplitude | lung, testis, brain, heart, pancreas, prostate, skeletal muscle, bone, spinal cord |
α2δ3 | Amplifying current density | Brain, heart, skeletal muscle |
α2δ4 | Increases current amplitude | Heart, skeletal muscle, intestine, fetal liver, erythroblasts, adrenal gland, pitutary |
β1 | Skeletal excitation-contraction coupling Trafficking α1 to membrane Activating/Inactivating calcium gating-kinetetics Voltage dependence Targeting of α11.1 to triads |
Skeletal muscle, brain |
β2 | Trafficking α1 to membrane Activating/Inactivating calcium gating-kinetetics Voltage dependence Targeting of α11.4 to retina |
Heart, lung, trachea, aorta, brain |
β3 | Trafficking α1 to membrane Activating/Inactivating calcium gating-kinetetics Voltage dependence |
Smooth muscle, trachea, aorta, lung, brain |
β4 | Trafficking α1 to membrane Regulating calcium gating-kinetetics Activating/Inactivating calcium gating-kinetetics |
Brain |
γ1 | Activating/Inactivating calcium gating-kinetetics Inhibiting channel function |
Skeletal muscle |
γ2 | Activating/Inactivating calcium gating-kinetetics Inhibiting channel function |
Brain |
γ3 | Activating/Inactivating calcium gating-kinetetics | Brain |
γ4 | Inactivating calcium gating-kinetetics | Heart, lunc, brain, prostate, spinal cord |
γ5 | ? | Brain |
γ6 | Reduces current aplitude | Heart, skeletal muscle, brain |
γ7 | Reduces current aplitude | Brain, heart, lung, testis |
γ8 | ? | Brain, testis, spinal cord |
Adapted from Arikkath J & Campbell KP (2003) [3]